Pharmaceutical Executive-04-23-2009

News Analysis
Pharmaceutical Executive

April 22, 2009

Stiefel Labs is under new management. The dermatology company was purchased by GSK in an effort to bolster its existing skincare line.

News Analysis
Pharmaceutical Executive

April 22, 2009

The two pharma giants announced plans to form a new specialty company focused on HIV drug development. The new, independent firm will have a total of 11 drugs on the market, with another six on the horizon, securing its place as a powerhouse in the HIV market.